IMA vs MOS · rev $9.2M vs P/E 161, rev $11.12B
ImageneBio, Inc. (IMA) versus The Mosaic Company (MOS) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported MOS revenue for 2024-12-31 was $11.12B. Net income was $202.0M. Revenue was down 18.8% from 2023-12-31 to 2024-12-31. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
IMA currently screens at market cap $64.7M. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Not investment advice. Open the IMA and MOS stock pages for the full models.
Not investment advice.